148 related articles for article (PubMed ID: 3947082)
1. In vitro studies of the mechanism of inhibition of rat liver uroporphyrinogen decarboxylase activity by ferrous iron under anaerobic conditions.
Mukerji SK; Pimstone NR
Arch Biochem Biophys; 1986 Feb; 244(2):619-29. PubMed ID: 3947082
[TBL] [Abstract][Full Text] [Related]
2. Dual mechanism of inhibition of rat liver uroporphyrinogen decarboxylase activity by ferrous iron: its potential role in the genesis of porphyria cutanea tarda.
Mukerji SK; Pimstone NR; Burns M
Gastroenterology; 1984 Dec; 87(6):1248-54. PubMed ID: 6489695
[TBL] [Abstract][Full Text] [Related]
3. The role of iron in the pathogenesis of porphyria cutanea tarda. II. Inhibition of uroporphyrinogen decarboxylase.
Kushner JP; Steinmuller DP; Lee GR
J Clin Invest; 1975 Sep; 56(3):661-7. PubMed ID: 1159079
[TBL] [Abstract][Full Text] [Related]
4. Activation of uroporphyrinogen decarboxylase by ferrous iron in porphyria cutanea tarda.
Blekkenhorst GH; Eales L; Pimstone NR
S Afr Med J; 1979 Nov; 56(22):918-20. PubMed ID: 515872
[TBL] [Abstract][Full Text] [Related]
5. Free radical mechanism of oxidation of uroporphyrinogen in the presence of ferrous iron.
Mukerji SK; Pimstone NR
Arch Biochem Biophys; 1990 Sep; 281(2):177-84. PubMed ID: 2168153
[TBL] [Abstract][Full Text] [Related]
6. Investigations of rat liver uroporphyrinogen decarboxylase. Comparisons of porphyrinogens I and III as substrates and the inhibition by porphyrins.
Smith AG; Francis JE
Biochem J; 1981 Apr; 195(1):241-50. PubMed ID: 7306050
[TBL] [Abstract][Full Text] [Related]
7. Some kinetic properties of human red cell uroporphyrinogen decarboxylase.
de Verneuil H; Grandchamp B; Nordmann Y
Biochim Biophys Acta; 1980 Jan; 611(1):174-86. PubMed ID: 7350915
[TBL] [Abstract][Full Text] [Related]
8. A potential biochemical explanation for the genesis of porphyria cutanea tarda. Studies on the inherent biochemical defect in highly purified human erythrocyte uroporphyrinogen decarboxylase and its amplification by iron.
Mukerji SK; Pimstone NR; Tan KT
FEBS Lett; 1985 Sep; 189(2):217-20. PubMed ID: 4043380
[TBL] [Abstract][Full Text] [Related]
9. Liver porphyrinogen carboxylase in hexachlorobenzene porphyric rats. Studies with intermediate porphyrinogens of series III and with uroporphyrinogen I.
Ríos de Molina MC; Wainstok de Calmanovici R; San Martín de Viale LC
Int J Biochem; 1987; 19(4):365-72. PubMed ID: 3595984
[TBL] [Abstract][Full Text] [Related]
10. Random decarboxylation of uroporphyrinogen III by human hepatic uroporphyrinogen decarboxylase.
Luo JL; Lim CK
J Chromatogr; 1991 May; 566(2):409-13. PubMed ID: 1939452
[TBL] [Abstract][Full Text] [Related]
11. Decarboxylation of porphyrinogens by rat liver uroporphyrinogen decarboxylase.
Smith AG; Francis JE
Biochem J; 1979 Nov; 183(2):455-8. PubMed ID: 534506
[TBL] [Abstract][Full Text] [Related]
12. Tetrapyrroles as substrates and inhibitors of porphyrinogen carboxy - lyase from rat liver.
San Martín de Viale LC; Aragonés A; Tomio JM
Acta Physiol Lat Am; 1976; 26(5):403-14. PubMed ID: 1052603
[TBL] [Abstract][Full Text] [Related]
13. Purification and characterization of bovine hepatic uroporphyrinogen decarboxylase.
Straka JG; Kushner JP
Biochemistry; 1983 Sep; 22(20):4664-72. PubMed ID: 6626522
[TBL] [Abstract][Full Text] [Related]
14. Porphyria-induced hepatic porphyrinogen carboxy-lyase inhibitor and its interaction with the active site(s) of the enzyme.
de Catabbi SB; de Calmanovici RW; Minutolo C; Aldonatti C; San Martin de Viale LC
Biochem Mol Biol Int; 1999 Jun; 47(6):945-56. PubMed ID: 10410240
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of uroporphyrinogen decarboxylase activity. The role of cytochrome P-450-mediated uroporphyrinogen oxidation.
Lambrecht RW; Jacobs JM; Sinclair PR; Sinclair JF
Biochem J; 1990 Jul; 269(2):437-41. PubMed ID: 2117439
[TBL] [Abstract][Full Text] [Related]
16. Decreased hepatic uroporphyrinogen decarboxylase activity in porphyria cutanea tarda.
Felsher BF; Carpio NM; Engleking DW; Nunn AT
N Engl J Med; 1982 Apr; 306(13):766-9. PubMed ID: 7062951
[TBL] [Abstract][Full Text] [Related]
17. Defective human erythrocyte uroporphyrinogen decarboxylase in familial porphyria cutanea tarda: the metabolic lesion or the result of endogenous porphyrinemia?
Mukerji SK; Pimstone NR
Biochem Biophys Res Commun; 1988 Jul; 154(1):39-46. PubMed ID: 3395340
[TBL] [Abstract][Full Text] [Related]
18. Decarboxylation of uroporphyrinogen III by erythrocyte uroporphyrinogen decarboxylase. Evidence for a random decarboxylation mechanism.
Luo J; Lim CK
Biochem J; 1990 Jun; 268(2):513-5. PubMed ID: 2363688
[TBL] [Abstract][Full Text] [Related]
19. Reduced substrate affinity for human erythrocyte uroporphyrinogen decarboxylase constitutes the inherent biochemical defect in porphyria cutanea tarda.
Mukerji SK; Pimstone NR
Biochem Biophys Res Commun; 1985 Mar; 127(2):517-25. PubMed ID: 3977935
[TBL] [Abstract][Full Text] [Related]
20. Mechanistic studies of the inhibition of hepatic uroporphyrinogen decarboxylase in C57BL/10 mice by iron-hexachlorobenzene synergism.
Smith AG; Francis JE; Kay SJ; Greig JB; Stewart FP
Biochem J; 1986 Sep; 238(3):871-8. PubMed ID: 3800966
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
